Article
OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients.
International journal of immunopharmacology - 1 Aug 1998
Takahashi K, Harauchi D, Kimura S, Saito S, Monden Y
Abstract excerpt
We examined the effect of OK-432 on induction of cytotoxic T lymphocytes (CTL) directed against autologous tumor cells (ATC) and lymphokine-activated killer (LAK) cells from mononuclear cells separated from regional lymph node cells (RLMNCs) of 49 lung cancer patients. We also examined the phenot...
Topics
- Aged
- Aged, 80 and over
- Antineoplastic Agents
- Female
- HLA-DR Antigens
- Humans
- Immunotherapy, Adoptive
- Intercellular Adhesion Molecule-1
- Interleukin-2
- Killer Cells, Lymphokine-Activated
- Lung Neoplasms
- Lymph Nodes
- Male
- Middle Aged
- Phenotype
- Picibanil
- T-Lymphocytes, Cytotoxic
